Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Gilliland

Showing results (21-30 of 182) with videos related to

Pageof 19
Sort By:
Nature Reviews. Clinical Oncology|February 29, 2012
Drug development and clinical trials--the path to an approved cancer drugEric H Rubin, D Gary Gilliland
Current Opinion in Hematology|June 4, 2002
Role of FLT3 in leukemiaD Gary Gilliland, James D Griffin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
The role of signal transducer and activator of transcription factors in leukemogenesisDavid W Sternberg, D Gary Gilliland
Annual Review of Genomics and Human Genetics|August 27, 2002
Genetics of myeloid leukemiasLouise M Kelly, D Gary Gilliland
Seminars in Cancer Biology|December 23, 2009
Leukemia stem cellsSteven W Lane, D Gary Gilliland
Nature Reviews. Cancer|April 2, 2005
Leukaemia stem cells and the evolution of cancer-stem-cell researchBrian J P Huntly, D Gary Gilliland
Cancer Cell|September 24, 2004
Blasts from the past: new lessons in stem cell biology from chronic myelogenous leukemiaBrian J P Huntly, D Gary Gilliland
Current Opinion in Oncology|January 16, 2002
Comprehensive genotypic analysis of leukemia: clinical and therapeutic implicationsLouise Kelly, Jennifer Clark, D Gary Gilliland
Seminars in Oncology|August 12, 2008
Deregulation of signaling pathways in acute myeloid leukemiaClaudia Scholl, D Gary Gilliland, Stefan Fröhling
Methods in Molecular Medicine|March 1, 2006
Detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemiaJan Cools, Elizabeth H Stover, D Gary Gilliland
Pageof 19

Showing results (21-30 of 182) with videos related to

Sort By:
Pageof 19
Nature Reviews. Clinical Oncology|February 29, 2012
Drug development and clinical trials--the path to an approved cancer drugEric H Rubin, D Gary Gilliland
Current Opinion in Hematology|June 4, 2002
Role of FLT3 in leukemiaD Gary Gilliland, James D Griffin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
The role of signal transducer and activator of transcription factors in leukemogenesisDavid W Sternberg, D Gary Gilliland
Annual Review of Genomics and Human Genetics|August 27, 2002
Genetics of myeloid leukemiasLouise M Kelly, D Gary Gilliland
Seminars in Cancer Biology|December 23, 2009
Leukemia stem cellsSteven W Lane, D Gary Gilliland
Nature Reviews. Cancer|April 2, 2005
Leukaemia stem cells and the evolution of cancer-stem-cell researchBrian J P Huntly, D Gary Gilliland
Cancer Cell|September 24, 2004
Blasts from the past: new lessons in stem cell biology from chronic myelogenous leukemiaBrian J P Huntly, D Gary Gilliland
Current Opinion in Oncology|January 16, 2002
Comprehensive genotypic analysis of leukemia: clinical and therapeutic implicationsLouise Kelly, Jennifer Clark, D Gary Gilliland
Seminars in Oncology|August 12, 2008
Deregulation of signaling pathways in acute myeloid leukemiaClaudia Scholl, D Gary Gilliland, Stefan Fröhling
Methods in Molecular Medicine|March 1, 2006
Detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemiaJan Cools, Elizabeth H Stover, D Gary Gilliland
Pageof 19